MCUJF News and Press, Medicure Inc From 12/05/19

Medicure Files Patent Infringement Action Canada NewsWire WINNIPEG, Dec. 5, 2019 WINNIPEG , Dec. 5, 2019 /CNW/ - Medicure Inc. (" Medicure ") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc....

The following slide deck was published by Medicure Inc. in conjunction with their 2019 Q3 earnings Read more ...

Start Time: 08:30 End Time: 08:48 Medicure Inc. (MCUJF) Q3 2019 Earnings Conference Call November 27, 2019, 08:30 AM ET Company Participants Albert Friesen - Chairman and CEO James Kinley - CFO Neil Owens - President and COO Conference Call Participants Presentation ...

Medicure ( OTCPK:MCUJF ): Q3 GAAP EPS of -C$0.04. More news on: Medicure Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

WINNIPEG , Nov. 26, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter ended September 30 , 2019.  Quarter Ended September 30, 2019 ...

Medicure Q3 2019 Results and Conference Call Dates Canada NewsWire WINNIPEG, Nov. 19, 2019 WINNIPEG , Nov. 19, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, will release financial results for the...

WINNIPEG , Nov. 13, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, today announced the commencement of its previously announced substantial issuer bid (the " Offer "), pursuant to which the Company...

Medicure Announces Intention to Commence Substantial Issuer Bid Canada NewsWire WINNIPEG, Nov. 4, 2019 WINNIPEG , Nov. 4, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced its inte...

WINNIPEG , Oct. 15, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILE TM -Heart Failure (SMILE-HF) Clinical Trial which was presented at the ...

WINNIPEG , Oct. 3, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJD.PK), a cardiovascular pharmaceutical company, is pleased to announce that it has reached a preferred pricing agreement with the AIDS Drug Assistance Program (ADAP) Crisis Task ...